Megestrol vs oxandrolone for HIV-related weight loss

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1438, 2004-01, pp. : 12-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oxandrolone has beneficial effects in patients with bodyweight loss associated with HIV infection

By  

Inpharma, Vol. 1, Iss. 1247, 2000-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Strategies for treating HIV-related lipodystrophy

By García-Viejo Miguel Angel   Ruíz Mónica   Martínez Esteban  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 8, 2001-08 ,pp. : 1443-1456

Informa Healthcare

Access to resources Recommend Favorite

HIV-Related Cardiovascular Disease and Drug Interactions

By Kinjal A. Nanavati  

American Journal of Cardiovascular Drugs, Vol. 4, Iss. 5, 2004-01 ,pp. : 315-324

Adis International

Access to resources Recommend Favorite

HIV-Related Movement Disorders: Epidemiology, Pathogenesis and Management

By Cardoso F.  

CNS Drugs, Vol. 16, Iss. 10, 2002-01 ,pp. : 663-668

Adis International

Access to resources Recommend Favorite

HAART improves outcomes in patients with HIV-related HD

By  

Inpharma, Vol. 1, Iss. 1364, 2002-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite